Janney Capital Management’s Edwards Lifesciences EW Stock Holding History

Janney Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,500	Closed	-$359K	–	207
2020 Q3	$359K	Hold	4,500	–	–	0.02%	161
2020 Q2	$311K	Hold	4,500	–	–	0.02%	162
2020 Q1	$283K	Sell	4,500 -1,140	-20%	-$82.2K	0.02%	159
2019 Q4	$439K	Hold	5,640	–	–	0.02%	157
2019 Q3	$413K	Sell	5,640 -132	-2%	-$9.27K	0.02%	155
2019 Q2	$355K	Sell	5,772 -9	-0.2%	-$544	0.02%	155
2019 Q1	$369K	Sell	5,781 -156	-3%	-$8.9K	0.02%	151
2018 Q4	$303K	Buy	5,937 +165	+3%	+$8.35K	0.02%	162
2018 Q3	$335K	Sell	5,772 -4,500	-44%	-$220K	0.01%	180
2018 Q2	$498K	Hold	10,272	–	–	0.02%	140
2018 Q1	$478K	Hold	10,272	–	–	0.02%	138
2017 Q4	$385K	Hold	10,272	–	–	0.02%	161
2017 Q3	$374K	Buy	+10,272	New	+$392K	0.02%	166

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Janney Capital Management's EW Position: Q4 2020 in Review

Janney Capital Management sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 4,500 shares — an estimated $359K sold.

Janney Capital Management first reported a position in EW in Q3 2017 and held it in 13 quarters. The position peaked at $498K in Q2 2018. 1,160 funds tracked by Wall St. Rank hold EW as of Q4 2020.

Janney Capital Management reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
Janney Capital Management sold 4,500 Edwards Lifesciences shares in Q4 2020, an estimated $359K.
Janney Capital Management first reported a position in Edwards Lifesciences in Q3 2017 and held it in 13 quarters.
Janney Capital Management's Edwards Lifesciences position peaked at $498K in Q2 2018.
1,160 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Janney Capital Management's 13F filing for Q4 2020, filed 25 Jan 2021.